Interaction between serum cotinine and body mass index on asthma in the children: a cross-sectional study

Li He1, Xiaojing Xi2

  • 1School of Medicine, Xinjiang University of Science & Technology, No.89, Beijing Road, Yingxia Township, 841000, Korla City, Xinjiang, People's Republic of China. lihexjmu@outlook.com.

BMC Pediatrics
|August 23, 2022
PubMed

Insights

Environmental tobacco smoke exposure, indicated by serum cotinine, and high body mass index (BMI) synergistically increase childhood asthma risk. Interventions targeting weight and smoke exposure are crucial for affected children.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Epidemiology

Background:

  • Childhood asthma is a significant public health concern.
  • Environmental tobacco smoke exposure is a known risk factor for asthma development and exacerbation.
  • Obesity is also increasingly recognized as a contributing factor to asthma prevalence and severity in children.

Purpose of the Study:

  • To investigate the interaction between serum cotinine levels, a biomarker for environmental tobacco smoke exposure, and body mass index (BMI) on the risk of childhood asthma.
  • To determine if a synergistic relationship exists between these two factors in the development of asthma.

Main Methods:

  • Utilized a cross-sectional study design using data from the National Health and Nutrition Examination Survey (1999-2018).
  • Included 11,504 American children aged 3-12 years.
  • Employed multivariate logistic regression to analyze associations and interactions between serum cotinine, BMI z-score, and asthma, controlling for potential confounders. Serum cotinine was dichotomized, and interaction analyses were performed in subgroups.

Main Results:

  • High serum cotinine levels were significantly associated with increased asthma risk (OR=1.190).
  • Overweight (OR=1.275) and obesity (OR=1.636) were significantly associated with higher asthma risk compared to normal weight.
  • A significant synergistic interaction was observed between serum cotinine levels and BMI on childhood asthma (Synergy Index=1.617), indicating a combined effect greater than the sum of individual effects. This interaction was consistent across age and ethnicity subgroups.

Conclusions:

  • A significant synergistic interaction exists between environmental tobacco smoke exposure and overweight/obesity in contributing to childhood asthma.
  • Interventions aimed at reducing both passive smoking exposure and excess weight in children are essential for asthma prevention and management.
  • Public health strategies should address both environmental and lifestyle factors to mitigate the burden of childhood asthma.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
549
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K